Gross Margin
21.83%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 18.93%.Updated Sep 19, 2026Profit Margin
6.40%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Margin
12.43%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Assets (TTM)
3.10%vs Specialty Chemicals peers Updated Sep 19, 2026Return on Equity (TTM)
11.47%vs Specialty Chemicals peers Updated Sep 19, 2026Revenue (TTM)
569.91BKRW411.36M · vs all stocks (USD) Updated Sep 19, 2026Revenue per Share (TTM)
5.31KKRWUpdated Sep 19, 2026Quarterly Revenue Growth
51.50%vs Specialty Chemicals peers Updated Sep 19, 2026Gross Profit (TTM)
107.88BKRW77.87M · vs all stocks (USD) Updated Sep 19, 2026EBITDA (TTM)
90.76BKRW65.51M · vs all stocks (USD) Updated Sep 19, 2026Net Income (TTM)
36.45BKRW26.31M · vs all stocks (USD) Updated Sep 19, 2026Quarterly Earnings Growth (YoY)
51.54%vs Specialty Chemicals peers Updated Sep 19, 2026Operating Cash Flow (TTM)
23.80BKRW17.18M · vs all stocks (USD) Updated Sep 19, 2026Levered Free Cash Flow (TTM)
28.02BKRW20.22M · vs all stocks (USD) Updated Sep 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 19, 2026Minority Interest (Equity)
54.98BKRWFY2025 · Dec 31, 2025Revenue
471.56BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
383.76BKRWFY2025 · Dec 31, 2025Gross Profit
87.80BKRWFY2025 · Dec 31, 2025Operating Income
25.35BKRW18.30M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
19.24BKRWFY2025 · Dec 31, 2025Income Tax Expense
12.21BKRWFY2025 · Dec 31, 2025Net Income
7.03BKRWFY2025 · Dec 31, 2025EBIT
34.93BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
55.48BKRWFY2025 · Dec 31, 2025Research & Development
10.97BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
24.79BKRWFY2025 · Dec 31, 2025Other Operating Expenses
8.80MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
3.30BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
15.69BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
7.03BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.72BKRWFY2025 · Dec 31, 2025Operating Cash Flow
60.97BKRWFY2025 · Dec 31, 2025Free Cash Flow
22.26BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
67.70BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
7.03BKRWFY2025 · Dec 31, 2025Other Non-cash Items
32.55BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
29.09BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-7.70BKRWFY2025 · Dec 31, 2025Capital Expenditures
-38.71BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-69.63MKRWFY2025 · Dec 31, 2025Net Acquisitions
-2.04BKRWFY2025 · Dec 31, 2025Purchase of Investments
-255.84BKRWFY2025 · Dec 31, 2025Sale of Investments
291.48BKRWFY2025 · Dec 31, 2025Other Investing Activity
-900.40MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-6.01BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
95.20BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-175.74BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-48.00BKRWFY2025 · Dec 31, 2025Other Financing Charges
35.56BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
-92.99BKRWFY2025 · Dec 31, 2025